About Fibrin Sealants
Fibrin sealant, a two-component substance consisting of thrombin and fibrinogen, is used as a hemostatic or adhesive in various surgical solutions. In clinical practice, a fibrin sealant consists of a concentrated solution of fibrinogen and Factor XIII, which combine with a solution of calcium and thrombin to form a coagulum that stimulates clotting. Beriplast P and TISSEEL are some of the commercially available fibrin sealants.
Technavio’s analysts forecast the global fibrin sealants market to grow at a CAGR of 9.14% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global fibrin sealants market for 2016-2020. To calculate the market size, the report considers the revenue generated from fibrin sealants from the following regions
Technavio Announces the Publication of its Research Report – Global Fibrin Sealants Market 2016-2020
Technavio recognizes the following companies as the key players in the Global Fibrin Sealants Market: Baxter International, CSL Behring and Johnson & Johnson (Ethicon).
Other Prominent Vendors in the market are: Asahi Kasei Medical, C.R. Bard (Bard Medical, Davol), Hualan Biological, Harvest Technologies, Kaketsuken, LifeBond, Pharming Group, Sea Run, Shanghai RAAS, STB Lifesaving Technologies, Tissuemed, and Z-Medica.
Commenting on the report, an analyst from Technavio’s team said: “The approval for the use of fibrin sealants in extended applications has helped many vendors develop innovative fibrin sealants, which have two or more applications. For instance, a fibrin sealant can be used in tissue sealing of a particular organ and in general tropical surgery.”
According to the report, increase in the number of ambulatory surgical centers is likely to drive the market during the forecast period. These centers are inexpensive and easily accessible to patients. Also, ambulatory surgeries do not require overnight hospital stays. The rising popularity of ambulatory surgical centers has increased the number of patient visits, thereby increasing the number of surgeries being performed and demand for wound closure products, including fibrin sealants.
Further, the report states that the availability of alternative products such as foams and adhesives for fibrin sealants would limit their adoption and impede market growth.
Baxter International, CSL Behring, Johnson & Johnson (Ethicon), Asahi Kasei Medical, C.R. Bard (Bard Medical, Davol), Hualan Biological, Harvest Technologies, Kaketsuken, LifeBond, Pharming Group, Sea Run, Shanghai RAAS, STB Lifesaving Technologies, Tissuemed, Z-Medica.